Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of JTT-851 in Type 2 Diabetes Mellitus
jRCT2080221688Phase 2
- Sponsor
- Japan Tobacco
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of JTT-851 in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Japan Tobacco.
02
Drugs
JTT-851
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT2080221688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221688.